EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Post transfusion cytomegalovirus and newborn infants infection and prevention






Revue Francaise de Transfusion et Immuno-Hematologie 27(3): 345-354

Post transfusion cytomegalovirus and newborn infants infection and prevention

More severe post-transfusion cytomegalovirus infections (PTCMV) develop in infants born of uninfected mothers (CMV seronegative mothers). These newborns have no passively acquired maternal antibodies which probably prevent or limit the spread of PTCMV infection in infants born of CMV seropositive mothers. Almost all transfused newborns are premature and many of them receive > 10 micro-transfusions of red blood cells. Thus, their risk of developing CMV infection is high (10-20%). The limited immune competence of these newborns and the fact that many already suffer from other developmental defects explain the severity of these PTCMV infections. Prevention of PTCMV infections is possible by using blood from CMV seronegative donors. Frozen blood also appears effective.


Accession: 006153488



Related references

Brossard, Y.; Parnet-Mathieu, F., 1984: Post-transfusion cytomegalovirus infection in newborn infants. Post-transfusional cytomegalovirus infection (P.T.C.M.V.) represents a minor part (perhaps about 0.2%) when compared with C.M.V. infections or maternal origin (congenital 0.2-0.5% - post-natal first year 20%). However P.T.C.M.V. infections are ass...

Gilbert, G.L.; Hayes, K.; Hudson, I.L.; James, J., 1989: Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. A multicentre, controlled trial was carried out to determine whether removal of leucocytes from blood by means of 'Imugard IG500' (Terumo) filters would prevent transfusion-acquired cytomegalovirus (CMV) infection in newborn infants. 72...

Primhak, R.A.; Duffty, P.; Becker, L.E., 1983: Prevention of transfusion-acquired cytomegalovirus in newborn infants. Journal of Pediatrics 102(6): 1013-1013

Yeager, A.S.; Grumet, F.C.; Hafleigh, E.B.; Arvin, A.M.; Bradley, J.S.; Prober, C.G., 1981: Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. Transfusion-acquired cytomegalovirus infections occurred in 13.5% of 74 infants of seronegative mothers who were exposed to one or more blood donors who had a CMV indirect hemagglutination titer of 1:8 or higher. None of 90 infants of seronegative...

Adler, S.P.; Lawrence, L.T.; Baggett, J.; Biro, V.; Sharp, D.E., 1984: Prevention of transfusion-associated cytomegalovirus infection in very low-birthweight infants using frozen blood and donors seronegative for cytomegalovirus. During a 15-month period, 34 low birthweight infants (less than 1300 g) lacking maternal antibody to cytomegalovirus (CMV) received transfusions from an average of 10 donors per infant. Blood products consisted of predominantly washed deglyceroliz...

Yeager, A.S., 1974: Transfusion-acquired cytomegalovirus infection in newborn infants. American Journal of Diseases of Children 128(4): 478-483

Hart, S.; Boughton, B.J., 1989: Prevention of transfusion-acquired cytomegalovirus infection in infants. Lancet 2(8661): 502-502

Hubert, C.; Janot, C.; Georges, J.C.; van Melkebecke, E.; Andre, M.; Vert, P., 1989: Post-transfusion cytomegalovirus infection in premature infants weighing less than 1,500 g. The incidence of cytomegalovirus (CMV) infection among 107 low birth weight transfused infants (birth weight less than or equal to 1,500 g) admitted to an intensive care nursery over an 18 month period was evaluated. The diagnosis of CMV infection...

Zwicky, C.; Tissot, J.D.; Mazouni, Z.T.; Schneider, P.; Burnand, B., 1999: Prevention of post-transfusion cytomegalovirus infection: recommendations for clinical practice. Based on a review of the literature, guidelines for the clinical use of cytomegalovirus (CMV) seronegative cellular blood products are presented. The clinical fields of application include obstetrics and foetal, neonatal, and transplantation medic...

Gilbert G.L.; Hayes K.; Hudson I.L.; James J.; Neonatal Cytomegalovirus Infect Study Group (Aust), 1989: Prevention of transfusion acquired cytomegalovirus infection in infants by blood filtration to remove leukocytes. A multicentre, controlled trial was carried out to determine whether removal of leucocytes from blood by means of 'Imugard IG500' (Terumo) filters would prevent transfusion-acquired cytomegalovirus (CMV) infection in newborn infants. 72...